Med-Tech Innovation September 6, 2024

For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.

Developed by Samphire Neuroscience, a neurotechnology company based in London, this device leverages recent findings that show hormonal fluctuations during the menstrual cycle can alter brain activity, structure, and function. By harnessing the brain-cycle connection, Samphire has adapted a technique once limited to specialised clinics into an at-home wearable device that goes by the name Nettle.

This approach reprogrammes how the brain perceives symptoms and offers a medically certified and clinically tested solution that outperforms traditional treatments.

The impact of menstrual symptoms on quality of life

Over 90% of females of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article